Blood Cancer Journal, 2044-5385
Journal
1 - 5 out of 5Page size: 10
Publications
- 2020
- Accepted/In press
Anti-bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation, in Response to Therapy and in Remission: Implications for Patient Management
Ilaria Chicca, Jennifer Heaney, Alex Richter & Mark Drayson, 28 Sep 2020, (Accepted/In press) In: Blood Cancer Journal.Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma
Christian Ludwig, David Bartlett, Sarah Essex, Will Allwood, Helen Parry, Pip Nicolson, Warwick Dunn, Paul Moss, Dickens Pratt & Daniel Tennant, 16 Oct 2015, In: Blood Cancer Journal. 5, e359.Research output: Contribution to journal › Letter › peer-review
- 2013
- Published
BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia
Angelo Agathanggelou, Victoria Weston, Eva Petermann, Anastasia Zlatanou, Ceri Oldreive, Wenbin Wei, Grant Stewart, Emma Smith, Pamela Kearns & Tatjana Stankovic, Jul 2013, In: Blood Cancer Journal. 3, 7, e126.Research output: Contribution to journal › Article › peer-review
- 2012
- Published
Distinct regulation of c-myb gene expression by HoxA9, Meis1 and Pbx proteins in normal hematopoietic progenitors and transformed myeloid cells
Emilie Dasse, Giacomo Volpe, Doug Walton, Neil Wilson, Walter Del Pozzo, Laura O'Neill, Jon Frampton & Stephanie Dumon, Jun 2012, In: Blood Cancer Journal. 2, 6, p. e76Research output: Contribution to journal › Article › peer-review
- 2011
- Published
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
Farhat Khanim, Baz Jackson, Jane Birtwistle, Christopher Bunce & Mark Drayson, 1 Oct 2011, In: Blood Cancer Journal. 1, p. e39Research output: Contribution to journal › Article